Routine molecular profiling is the only way to
identify all potential patients candidates to receive
targeted treatment
•
Large-scale molecular testing challenges
–
Quality
–
Reproducibility
–
Unrestricted access
–
Adequate turn-around time
•
Routine molecular profiling in France
(Barlessi F. et al, Lancet 2016)
–
Feasibility of the implementation of large-scale nationwide
decentralized testing,
–
Tests free of charge for patients and institutions.
–
Improvement in the survival of about 50% of patients
1